Literature DB >> 35623007

Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.

Robert J Hamilton1, Christina Canil2, Noa Shani Shrem2, Kopika Kuhathaas3, Maria Di Jiang4, Peter Chung5, Scott North6, Piotr Czaykowski7, Sebastien Hotte8, Eric Winquist9, Christian Kollmannsberger10, Armen Aprikian11, Denis Soulières12, Scott Tyldesley13, Alan I So14, Nicholas Power15, Ricardo A Rendon16, Martin O'Malley17, Lori Wood18, Michael A S Jewett.   

Abstract

Entities:  

Year:  2022        PMID: 35623007      PMCID: PMC9245964          DOI: 10.5489/cuaj.7945

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   2.052


× No keyword cloud information.
  178 in total

1.  Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors.

Authors:  Joel Sheinfeld; Robert J Motzer; Farhang Rabbani; James McKiernan; Dean Bajorin; George J Bosl
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

2.  Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.

Authors:  Axel Heidenreich; Peter Albers; Michael Hartmann; Sabine Kliesch; Kai-Uwe Kohrmann; Susanne Krege; Philipp Lossin; Lothar Weissbach
Journal:  J Urol       Date:  2003-05       Impact factor: 7.450

3.  Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up.

Authors:  Graham M Mead; Sophie D Fossa; R Timothy D Oliver; Johnathan K Joffe; Robert A Huddart; J Trevor Roberts; Philip Pollock; Rhian Gabe; Sally P Stenning
Journal:  J Natl Cancer Inst       Date:  2011-01-06       Impact factor: 13.506

4.  Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.

Authors:  N Aass; O Klepp; E Cavallin-Stahl; O Dahl; H Wicklund; B Unsgaard; L Baldetorp; S Ahlström; S D Fosså
Journal:  J Clin Oncol       Date:  1991-05       Impact factor: 44.544

5.  Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline.

Authors:  Andrew Stephenson; Scott E Eggener; Eric B Bass; David M Chelnick; Siamak Daneshmand; Darren Feldman; Timothy Gilligan; Jose A Karam; Bradley Leibovich; Stanley L Liauw; Timothy A Masterson; Joshua J Meeks; Phillip M Pierorazio; Ritu Sharma; Joel Sheinfeld
Journal:  J Urol       Date:  2019-07-08       Impact factor: 7.450

6.  Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.

Authors:  Peter Albers; Roswitha Siener; Susanne Krege; Hans-Uwe Schmelz; Klaus-Peter Dieckmann; Axel Heidenreich; Peter Kwasny; Maik Pechoel; Jan Lehmann; Sabine Kliesch; Kai-Uwe Köhrmann; Rolf Fimmers; Lothar Weissbach; Volker Loy; Christian Wittekind; Michael Hartmann
Journal:  J Clin Oncol       Date:  2008-05-05       Impact factor: 44.544

Review 7.  Management of stage I non-seminomatous testicular cancer: a systematic review and meta-analysis.

Authors:  S J Hotte; L A Mayhew; M Jewett; J Chin; E Winquist
Journal:  Clin Oncol (R Coll Radiol)       Date:  2009-10-17       Impact factor: 4.126

8.  [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.

Authors:  Karin Oechsle; Michael Hartmann; Winfried Brenner; Stephan Venz; Lothar Weissbach; Christiane Franzius; Sabine Kliesch; Stephan Mueller; Susanne Krege; Ruediger Heicappell; Roland Bares; Carsten Bokemeyer; Maike de Wit
Journal:  J Clin Oncol       Date:  2008-11-17       Impact factor: 44.544

9.  Late relapse of testicular cancer.

Authors:  J Baniel; R S Foster; R Gonin; J E Messemer; J P Donohue; L H Einhorn
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

10.  Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.

Authors:  Silke Gillessen; Nicolas Sauvé; Laurence Collette; Gedske Daugaard; Ronald de Wit; Costantine Albany; Alexey Tryakin; Karim Fizazi; Olof Stahl; Jourik A Gietema; Ugo De Giorgi; Fay H Cafferty; Aaron R Hansen; Torgrim Tandstad; Robert A Huddart; Andrea Necchi; Christopher J Sweeney; Xavier Garcia-Del-Muro; Daniel Y C Heng; Anja Lorch; Michal Chovanec; Eric Winquist; Peter Grimison; Darren R Feldman; Angelika Terbuch; Marcus Hentrich; Carsten Bokemeyer; Helene Negaard; Christian Fankhauser; Jonathan Shamash; David J Vaughn; Cora N Sternberg; Axel Heidenreich; Jörg Beyer
Journal:  J Clin Oncol       Date:  2021-04-06       Impact factor: 44.544

View more
  2 in total

Review 1.  Testicular cancer survivorship: Long-term toxicity and management.

Authors:  Noa Shani Shrem; Lori Wood; Robert J Hamilton; Kopika Kuhathaas; Piotr Czaykowski; Matthew Roberts; Andrew Matthew; Jason P Izard; Peter Chung; Lucia Nappi; Jennifer Jones; Denis Soulières; Armen Aprikian; Nicholas Power; Christina Canil
Journal:  Can Urol Assoc J       Date:  2022-08       Impact factor: 2.052

2.  Updated testicular cancer consensus guideline is a concise, balanced, and practical guide for clinicians.

Authors:  Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2022-06       Impact factor: 2.052

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.